Prothena Corporation plc Live Stock Price Today, Share Analysis and Chart

Name: Prothena Corporation plc: Is Infosys Ltd. worth buying?
Item: Prothena Corporation plc
Rating: 1.38075
Author: Trendlyne DVM scores

about

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseas...

8.06 -0.10 (-1.23%)

64.03% Fall from 52W High

501.5K

XNAS Volume

XNAS 17 Sep, 2025 4:00 PM (EDT)

Not Eligible

Expensive Valuation

16.0 / 100

Technically Neutral

39.2 / 100

1Yr Price target upside is 49%

6 analysts

Prothena Corporation plc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Prothena Corporation plc Live Stock Price Today, Share Analysis and Chart

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseas...

64.03% Fall from 52W High

SWOT Analysis

Prothena Corporation plc Live Price Chart